(unrealized = non-cash yet) Profit 20% on Citigroup, expecting it will go higher as it just passed the former target 4.20; waiting it to reach 5.00. Hopefully overall market does not let me down. This New Passed Health Care Bill is really confusing me, cause it never happened before; some will benefit, but many won't.
As May 1st approaches, I am being more wary of FDA's announcement on Provenge from Dendreon ($DNDN)
I hold shares of Dendreon at avg $6.80 per share (if you followed my blog, you know when I jumped in).
Provenge is (sipuleucel-T) an active cellular immunotherapy that has completed three Phase III trials for the treatment of metastatic, castrate-resistant, (also known as androgen-independent or hormone-refractory) prostate cancer.
